Evidence map›Paper›PMID 31467306›Full record

ArticleScientific reports2019

Prophage protein RacR activates lysozyme LysN, causing the growth defect of E. coli JM83.

Qiongwei Tang, Meilin Feng, Bingbing Hou, Jiang Ye, Haizhen Wu, Huizhan Zhang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qiongwei TangState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Meilin FengState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Bingbing HouState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Jiang YeState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Haizhen WuState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. wuhzh@ecust.edu.cn.
Huizhan ZhangState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. huizhzh@ecust.edu.cn.
East China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prophage enriched the prokaryotic genome, and their transcriptional factors improved the protein expression network of the host. In this study, we uncovered a new prophage-prophage interaction in E. coli JM83. The Rac prophage protein RacR (GenBank accession no. AVI55875.1) directly activated the transcription of φ80dlacZΔM15 prophage lysozyme encoding gene 19 (GenBank accession no. ACB02445.1, renamed it lysN, lysozyme nineteen), resulting in the growth defect of JM83. This phenomenon also occurred in DH5α, but not in BL21(DE3) and MG1655 due to the genotype differences. However, deletion of lysN could not completely rescued JM83 from the growth arrest, indicating that RacR may regulate other related targets. In addition, passivation of RacR regulation was found in the late period of growth of JM83, and it was transmissible to daughter cells. Altogether, our study revealed part of RacR regulatory network, which suggested some advanced genetic strategies in bacteria.

Indexed as

BacteriophagesEscherichia coliHost-Pathogen InteractionsMuramidaseProphagesViral ProteinsMuramidaseViral Proteins

Identifiers

PMID31467306
PMCPMC6715736
OpenAlexW2971176269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.